Work

44022 Long-Term Efficacy of Continuous Risankizumab in Psoriasis by Body Region: An Updated Integrated Analysis From the LIMMitless Open-Label Extension Study

Year: 2023

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2023.07.758

Authors: Andrew Blauvelt, Melinda J. Gooderham, Mark Lebwohl, Cuiyong Yue, Michael Chen, Manish Patel, Huzefa Photowala, April W. Armstrong

Institutions: Oregon Medical Research Center, Queen's University, SKiN Health, Probity Medical Research, Icahn School of Medicine at Mount Sinai, AbbVie (United States), University of Southern California

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387016032

FWCI:

Cites:

Cited by:

Related to: 10